High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas

Clinical Cancer Research

Volumn 6, Issue 6, 2000, Pages 2189-2200

  Aronen, Hannu J ^a,b   Pardo, Francisco S ^a,c   Kennedy, David N ^a   Belliveau, John W ^a   Packard, Scott D ^a,d,e   Hsu, Dora ^a   Hochberg, Frederick H ^a   Fischman, Alan J ^f   Rosen, Bruce R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^e USA   (United States)

^f Building 149 ^*

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE;

ADULT; AGED; ARTICLE; BRAIN BLOOD VOLUME; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; FEMALE; GLIOMA; GLUCOSE TRANSPORT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LONGITUDINAL STUDY; MALE; MICROVASCULATURE; MORPHOMETRICS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

ADULT; AGED; ASTROCYTOMA; BLOOD VOLUME; BRAIN; BRAIN NEOPLASMS; FEMALE; GLIOMA; GLUCOSE; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; MICROCIRCULATION; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034131067     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Folkman, J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med., 285: 1182-1186, 1971.
2. Weidner, J. Intratumoral microvessel density as a prognostic factor in cancer. Am. J. Pathol., 147: 9-19, 1995.
3. Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1-8, 1991.
4. Weidner, N. Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow. J. Pathol., 184: 119-122, 1998.
5. Macchiarini, P., Fontanini, G., Hardin, M. J., Squartini, F., and Angeletti, C. A. Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet, 340: 145-146, 1992.
6. Chodak, G. W., Haudenschild, C., Gittes, R. F., and Folkman, J. Angiogenic activity as a marker of neoplasia and preneoplasia in lesions of the human bladder. Ann. Surg., 192: 762-771, 1980.
7. Dickinson, A., Fox, S., Persad, R., Hollyer, J., Sibley, G., and Harris, A. Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas. Br. J. Urol., 74: 762-766, 1994.
8. Bremer, G. Tumor angiogenesis: an independent prognostic parameter in cervical cancer. Am. J. Obstet. Gynecol., 174: 126-131, 1996.
9. Sillman, F., Boyce, J., and Fruchter, R. The significance of atypical vessels and neovascularization in cervical neoplasia. Am. J. Obstet. Gynecol., 139: 154-159, 1981.
10. Brem, S., Cotran, R., and Folkman, J. Tumor angiogenesis: a quantitative method for histologic grading. J. Natl. Cancer Inst., 48: 347-356, 1972.
11. Aronen, H. J., Gazit, I. E., Louis, D. N., Buchbinder, B. R., Pardo, F. S., Weisskoff, R. M., Harsh, G., Cosgrove, R., Halpern, E., Hochberg, F. H., and Rosen, B. R. Cerebral blood volume maps of gliomas: a comparison with tumor grade and histologic findings. Radiology, 191: 41-51, 1994.
12. Warburg, O. On the origin of cancer cells. Science (Washington DC), 123: 309-314, 1956.
13. 18F] fluorodeoxyglucose and positron emission tomography. Neurology, 32: 1323-1329, 1982.
14. Pardo, F. S., Aronen, H. J., Kennedy, D. N., Moulton, G., Paiva, K., Okunieff, P., Schmidt, E. V., Hochberg, F. H., Harsh, G. R., Fischman, A. J., Linggood, R. M., and Rosen, B. Functional cerebral imaging studies in the evaluation and radiotherapeutic treatment of patients with malignant glioma. Int. J. Radiat. Oncol. Biol. Phys., 30: 663-669, 1994.
15. Coleman, R. E., Hoffman, J. M., Hanson, M. W., Sostman, H. D., and Schold, S. C. Clinical application of PET for the evaluation of brain tumors. J. Nucl. Med., 32: 616-622, 1991.
16. Di Chiro, G. Positron emission tomography using (18F) fluorodeoxyglucose in brain tumors. Investig. Radiol., 22: 360-371, 1987.
17. Alavi, J. B., Alavi, A., Chawluk, J., Kushner, M., Powe, J., Hickey, W., and Reivich, M. Positron emission tomography in patients with glioma: a predicator of prognosis. Cancer (Phila.), 62: 1074-1078, 1988.
18. 82Rb positron emission tomography. J. Comput. Assist. Tomogr., 11: 563-570, 1987.
19. Di Chiro, G., Oldfield, E., Wright, D. C., De Michele, D., Katz, D. A., Patronas, N. J., Doppman, J. L., Larson, S. M., Ito, M., and Kufta, C. V. Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies. Am. J. Roentgenol., 150: 189-197, 1988.
20. Ricci, P., Karis, J., Heiserman, J., Fram, E., Bice, A., and Drayer, B. Differentiating recurrent tumor from radiation necrosis: time for reevaluation of positron emission tomography? Am. J. Neuroradiol., 19: 407-413, 1998.
21. Hanson, M. W., Glantz, M. J., Hoffman, J. M., Friedman, A. H., Burger, P., Schold, S. C., and Coleman, R. E. FDG-PET in the selection of brain lesions for biopsy. J. Comput. Assist. Tomogr., 15: 796-801, 1991.
22. Levivier, M., Goldman, S., Pirotte, B., Brucher, J., Baleriaux, D., Luxen, A., Hildebrand, J., and Brotchi, J. Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F]fluorodeoxyglucose. J. Neurosurg., 82: 445-452, 1995.
23. Francavilla, T. L., Miletich, R. S., DiChiro, G., Patronas, N. J., Rizzoli, H. V., and Wright, D. C. Positron emission tomography in the detection of malignant degeneration of low-grade gliomas. Neurosurgery, 24: 1-5, 1989.
24. Goldman, S., Levivier, M., Pirotte, B., Brucher, J., Wikler, D., Damhaut, P., Stanus, E., Brotchi, J., and Hildebrand, J. Regional glucose metabolism and histopathology of gliomas. A study based on positron emission tomography-guided stereotactic biopsy. Cancer (Phila.), 78: 1098-1106, 1996.
25. Belliveau, J. W., Kennedy, D. N., McKinstry, R. C., Buchbinder, B. R., Weisskoff, R. M., Vevea, J. M., Cohen, M. S., Brady, T. J., and Rosen, B. R. Functional mapping of the human visual cortex using magnetic resonance imaging. Science (Washington DC), 254: 716-719, 1991.
26. Rosen, B. R., Belliveau, J. W., Buchbinder, B. R., McKinstry, R. C., Porkka, L. M., Kennedy, D. N., Neuder, M. S., Fisel, C. R., Aronen, H. J., Kwong, K. K., Weisskoff, R. M., Cohen, M. S., and Brady, T. J. Contrast agents and cerebral hemodynamics. Magn. Reson. Med., 19: 285-292, 1991.
27. Belliveau, J. W., Cohen, M. S., Weisskoff, R. M., Buchbinder, B. R., and Rosen, B. R. Functional studies of the human brain using high-speed magnetic resonance imaging. J. Neuroimaging, 1: 36-41, 1991.
28. Boxerman, J. L., Hamberg, L. M., Rosen, B. R., and Weisskoff, R. M. MR contrast due to intravascular magnetic susceptibility perturbations, Magn. Reson. Med., 34: 555-566, 1995.
29. Fisel, C. R., Ackerman, J. L., Buxton, R. B., Garrido, L., Belliveau, J. W., Rosen, B. R., and Brady, T. J. MR contrast due to microscopically heterogeneous magnetic susceptibility: numerical simulations and applications to cerebral physiology. Magn. Reson. Med., 17: 336-347, 1991.
30. Daumas-Duport, C., Scheithauer, B., O'Fallon, J., and Kelly, P. Grading of astrocytomas. A simple and reproducible method. Cancer (Phila.), 62: 2152-2165, 1988.
31. Filipek, P. A., Kennedy, D. N., Caviness, V. S., Rossnick, S. L., Spraggins, T. A., and Starewicz, P. M. Magnetic resonance imaging-based brain morphometry: development and application to normal subjects. Ann. Neurol., 25: 61-67, 1989.
32. Litton, J., Bergström, M., Ericksson, L., Bohm, C., and Blomqvist, G. Performance study of the PC-384 PET camera for the brain. J. Comput. Assist. Tomogr., 8: 74-87, 1984.
33. Rota Kops, E., Herzog, H., Schmid, A., Holte, S., and Feinendegen, L. E. Performance characteristics of an eight-ring whole body PET scanner. J. Comput. Assist. Tomogr., 14: 437-445, 1990.
34. Bergstrom, M., Eriksson, L., Böhm, C., Blomqvist, G., and Litton, J. Correction for scattered radiation in a ring detector positron camera by integral transformation of the projections. J. Comput. Assist. Tomogr., 7: 42-50, 1983.
35. Alpert, N., Barker, W., Gelman, A., Weise, S., Senda, M., and Correia, J. The precision of positron emission tomography: theory and experiment., J. Cereb. Blood Flow Metab., 11: A26-A30, 1991.
36. Kohlberger, P., Obermair, A., Sliutz, G., Heinzl, H., Koelbl, H., Breitenecker, G., Gitsch, G., and Kainz, C. Quantitative immunohistochemistry of factor VIII-related antigen in breast carcinoma: a comparison of computer-assisted image analysis with established counting methods. Am. J. Clin. Pathol., 105: 705-710, 1996.
37. Rosen, B. R., Belliveau, J. W., Vevea, J. M., and Brady, T. J. Perfusion imaging with NMR contrast agents. Magn. Reson. Med., 14: 249-265, 1990.
38. Belliveau, J. W., Rosen, B. R., Kantor, H. L., Rzedzian, R. R., Kennedy, D. N., McKinstry, R. C., Vevea, J. M., Cohen, M. S., Pykett, I. L., and Brady, T. J. Functional cerebral imaging by susceptibility-contrast NMR. Magn. Reson. Med., 14: 538-546, 1990.
39. Weisskoff, R. M., Zuo, C. S., Boxerman, J. L., and Rosen, B. R. Microscopic susceptibility variation and transverse relaxation: theory and experiment. Magn. Reson. Med., 31: 601-610, 1994.
40. Alpert, N. M., Bradshaw, J. F., Kennedy, D. N., and Correia, J. A. The principle axis transformation - a method for image registration. J. Nucl. Med., 31: 1717-1722, 1990.
41. Rosen, B. R., Belliveau, J. W., Aronen, H. J., Kennedy, D., Buchbinder, B. R., Fischman, A., Gruber, M., Glass, J., Weisskoff, R. M., Cohen, M. S., Hochberg, F. H., and Brady, T. Susceptibility contrast imaging of cerebral blood volume: human experience. Magn. Reson. Med., 22: 293-299, 1991.
42. Dennie, J., Mandeville, J., Boxerman, J., Packard, S., Rosen, B., and Weisskoff, R. NMR imaging of changes in vascular morphology due to tumor angiogenesis. Magn. Reson. Med., 40: 793-799, 1998.
43. Mineura, K., Sasajima, T., Kowada, M., Ogawa, T., Hatazawa, J., Shishido, F., and Uemura, K. Perfusion and metabolism in predicting the survival of patients with cerebral gliomas. Cancer (Phila.), 73: 2386-2394, 1994.
44. Lammertsma, A. A., Wise, R. J. S., Cox, T. C. S., Thomas, D. G. T., and Jones, T. Measurement of blood flow, oxygen utilisation, oxygen extraction ratio, and fractional blood volume in human brain tumours and surrounding oedematous tissue. Br. J. Radiol., 58: 725-734, 1985.
45. Tyler, J. L., Diksic, M., Villemure, J-G., Evans, A. C., Meyer, E., Yamamoto, Y. L., and Feindel, W. Metabolic and hemodynamic evaluation of gliomas using positron emission tomography. J. Nucl. Med., 28: 1123-1133, 1987.
46. Maxwell, M., Naber, S. P., Wolfe, H. S., Hedley-Whyte, E. T., Galanopoulos, T., Neville-Golden, J., and Antoniades, H. N. Expression of angiogenic growth factor genes in primary human astrocytomas may contribute to their growth and progression. Cancer Res., 51: 1345-1351, 1991.
47. Abdulrauf, S., Edvardsen, K., Ho, K., Yang, X., Rock, J., and Rosenblum, M. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma. J. Neurosurg., 88: 513-520, 1998.
48. Streffer, C. Glucose-, energy-metabolism and cell proliferation in tumors. Adv. Exp. Med. Biol., 345: 327-333, 1994.
49. Cordon-Cardo, C., and Sheinfeld, J. Molecular and immunopathology studies of oncogenes and tumor-suppressor genes in bladder cancer. World J. Urol., 15: 112-119, 1997.
50. Folkman, J., and D'Amore, P. Blood vessel formation: what is its molecular basis? Cell, 87: 1153-1155, 1996.